Circadian rhythm and its role in malignancy

Journal of Circadian Rhythms

Volumn 8, Issue , 2010, Pages

  Rana, Sobia ^a   Mahmood, Saqib ^a  

^a UNIVERSITY OF HEALTH SCIENCES   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

CRYPTOCHROME; CRYPTOCHROME 1; CYCLIN D1; GLYCOGEN SYNTHASE KINASE 3; HISTONE ACETYLTRANSFERASE; PER1 PROTEIN; PER2 PROTEIN; PROTEIN BMAL1; SIRTUIN 1; TRANSCRIPTION FACTOR CLOCK;

APOPTOSIS; CANCER GENETICS; CANCER INHIBITION; CANCER RISK; CARCINOGENESIS; CELL CYCLE; CELL PROLIFERATION; CHRONOTHERAPY; CIRCADIAN RHYTHM; DNA DAMAGE; ENZYME ACTIVITY; GENE DISRUPTION; GENE EXPRESSION; GENOMIC INSTABILITY; HUMAN; LIFESTYLE; NEOPLASM; NONHUMAN; OSCILLATOR; PROTEIN FUNCTION; REVIEW; SUPRACHIASMATIC NUCLEUS;

EID: 77950408376     PISSN: None     EISSN: 17403391     Source Type: Journal    
DOI: 10.1186/1740-3391-8-3     Document Type: Review

References (147)

1. Panda S, Hogenesh JB, Kay SA. Circadian rhythms from flies to humans. Nature 2002, 417:330-335.
2. Reppert SM, Weaver DR. Coordination of circadian timing in mammals. Nature 2002, 418:935-941. 10.1038/nature00965, 12198538.
3. Hastings MH, Reddy AB, Maywood ES. A clockwork web: circadian timing in brain and periphery, in health and disease. Nat Rev Neurosci 2003, 4:649-661. 10.1038/nrn1177, 12894240.
4. Morse D, Sassone-Corsi P. Time after time: inputs to and outputs from the mammalian circadian oscillators. Trends Neurosci 2002, 25:632-637. 10.1016/S0166-2236(02)02274-9, 12446131.
5. Lowrey PL, Takahashi JS. Mammalian circadian biology: elucidating genome-wide levels of temporal organization. Annu Rev Genomics Hum Genet 2004, 5:407-441. 10.1146/annurev.genom.5.061903.175925, 15485355.
6. Kondratov RV, Gorbacheva VY, Antoch MP. The role of mammalian circadian proteins in normal physiology and genotoxic stress responses. Curr Top Dev Biol 2007, 78:173-216. full_text, 17338917.
7. Weaver DR. The suprachiasmatic nucleus: a 25-year retrospective. J Biol Rhythms 1998, 13:100-112. 10.1177/074873098128999952, 9554572.
8. Welsh DK, Logothetis DE, Meister M, Reppert SM. Individual neurons dissociated from rat suprachiasmatic nucleus express independently phased circadian firing rhythms. Neuron 1995, 14:697-706. 10.1016/0896-6273(95)90214-7, 7718233.
9. Liu C, Weaver DR, Strogatz SH, Reppert SM. Cellular construction of a circadian clock: period determination in the suprachiasmatic nuclei. Cell 1997, 91:855-860. 10.1016/S0092-8674(00)80473-0, 9413994.
10. Czeisler CA, Shanahan TL, Klerman EB, Martens H, Brotman DJ, Emens JS, Klein T, Rizzo JF. Suppression of melatonin secretion in some blind patients by exposure to bright light. N Engl J Med 1995, 332:6-11. 10.1056/NEJM199501053320102, 7990870.
11. Freedman MS, Lucas RJ, Soni B, von Schantz M, Munoz M, David-Gray ZK, Foster RG. Regulation of mammalian circadian behavior by non-rod, non-cone, ocular photoreceptors. Science 1999, 284:502-504. 10.1126/science.284.5413.502, 10205061.
12. Lucas RJ, Freedman MS, Munoz M, Garcia-Fernandez JM, Foster RG. Regulation of the mammalian pineal by non-rod, non-cone, ocular photoreceptors. Science 1999, 284:505-507. 10.1126/science.284.5413.505, 10205062.
13. Gooley JJ, Lu J, Chou TC, Scammell TE, Saper CB. Melanopsin in cells of origin of the retinohypothalamic tract. Nature Neurosci 2001, 4:1165. 10.1038/nn768, 11713469.
14. Hattar S, Liao HW, Takao M, Berson DM, Yau KW. Melanopsin-containing retinal ganglion cells: architecture, projections, and intrinsic photosensitivity. Science 2002, 295:1065-1070. 10.1126/science.1069609, 11834834.
15. Panda S, Sato TK, Castrucci AM, Rollag MD, DeGrip WJ, Hogenesch JB, Provencio I, Kay SA. Melanopsin (Opn4) requirement for normal light-induced circadian phase shifting. Science 2002, 298:2213-2216. 10.1126/science.1076848, 12481141.
16. Cermakian N, Sassone-Corsi P. Environmental stimulus perception and control of circadian clocks. Curr Opin Neurobiol 2002, 12:359-365. 10.1016/S0959-4388(02)00347-1, 12139981.
17. Schibler U, Ripperger J, Brown SA. Peripheral circadian oscillators in mammals: time and food. J Biol Rhythms 2003, 18:250-260. 10.1177/0748730403018003007, 12828282.
18. Yoo SH, Yamazaki S, Lowrey PL, Shimomura K, Ko CH, Buhr ED, Siepka SM, Hong HK, Oh WJ, Yoo OJ, Menaker M, Takahashi JS. PERIOD2::LUCIFERASE real-time reporting of circadian dynamics reveals persistent circadian oscillations in mouse peripheral tissues. Proc Natl Acad Sci USA 2004, 101:5339-5346. 10.1073/pnas.0308709101, 397382, 14963227.
19. Damiola F, Le Minh N, Preitner N, Kornmann B, Fleury-Olela F, Schibler U. Restricted feeding uncouples circadian oscillators in peripheral tissues from the central pacemaker in the suprachiasmatic nucleus. Genes Dev 2000, 14:2950-2961. 10.1101/gad.183500, 317100, 11114885.
20. Stokkan KA, Yamazaki S, Tei H, Sakaki Y, Menaker M. Entrainment of the circadian clock in the liver by feeding. Science 2001, 291:490-493. 10.1126/science.291.5503.490, 11161204.
21. Balsalobre A, Marcacci L, Schibler U. Multiple signalling pathways elicit circadian gene expression in cultured rat-1 fibroblasts. Curr Biol 2000, 10:1291-1294. 10.1016/S0960-9822(00)00758-2, 11069111.
22. Brown S, Zumbrunn G, Fleury-Olela F, Preitner N, Schibler U. Rhythms of mammalian body temperature can sustain peripheral circadian clocks. Curr Biol 2002, 12:1574-1583. 10.1016/S0960-9822(02)01145-4, 12372249.
23. Bartness TJ, Song CK, Dernas GE. SCN efferents to peripheral tissues: implications for biological rhythms. J Biol Rhythms 2001, 16:196-204.
24. Kalsbeek A, Buijs RM. Output pathways of the mammalian suprachiasmatic nucleus: coding circadian time by transmitter selection and specific targeting. Cell Tissue Res 2002, 309:109-118. 10.1007/s00441-002-0577-0, 12111541.
25. Buijs RM, Wortel J, Van Heerikhuize JJ, Feenstra MGP, Ter Horst GJ, Romijn HJ, Kalsbeek A. Anatomical and functional demonstration of a multisynaptic suprachiasmatic nucleus adrenal (cortex) pathway. Eur J Neurosci 1999, 11:1535-1544. 10.1046/j.1460-9568.1999.00575.x, 10215906.
26. Schibler U, Sassone-Corsi P. A web of circadian pacemakers. Cell 2002, 111:919-22. 10.1016/S0092-8674(02)01225-4, 12507418.
27. Yagita K, Tamanini F, Horst GT, Okamura H. Molecular mechanisms of the biological clock in cultured fibroblasts. Science 2001, 292:278-281. 10.1126/science.1059542, 11303101.
28. Shearman LP, Sriram S, Weaver DR, Maywood ES, Chaves I, Zheng B, Kume K, Lee CC, Horst GT, Hastings MH, Reppert SM. Interacting molecular loops in the mammalian circadian clock. Science 2000, 288:1013-1019. 10.1126/science.288.5468.1013, 10807566.
29. Takahashi JS. Finding new clock components: past and future. J Biol Rhythms 2004, 19:339-347. 10.1177/0748730404269151, 15536063.
30. Gekakis N, Staknis D, Nguyen HB, Davis FC, Wilsbacher LD, King DP, Takahashi JS, Weitz CJ. Role of the CLOCK protein in the mammalian circadian mechanism. Science 1998, 280:1564-9. 10.1126/science.280.5369.1564, 9616112.
31. Ueda HR, Hayashi S, Chen W, Sano M, Machida M, Shigeyoshi Y, Iino M, Hashimoto S. System-level identification of transcriptional circuits underlying mammalian circadian clocks. Nat Genet 2005, 37:167-192.
32. Doi M, Hirayama J, Sassone-Corsi P. Circadian regulator CLOCK is a histone acetyltransferase. Cell 2006, 125:497-508. 10.1016/j.cell.2006.03.033, 16678094.
33. Kume K, Zylka MJ, Sriram S, Shearman LP, Weaver DR, Jin X, Maywood ES, Hastings MH, Reppert SM. mCRY1 and mCRY2 are essential components of the negative limb of the circadian clock feedback loop. Cell 1999, 98:193-205. 10.1016/S0092-8674(00)81014-4, 10428031.
34. Sato TK, Yamada RG, Ukai H, Baggs JE, Miraglia LJ, Kobayashi TJ, Welsh DK, Kay SA, Ueda HR, Hogenesch JB. Feedback repression is required for mammalian circadian clock function. Nat Genet 2006, 38:312-319. 10.1038/ng1745, 1994933, 16474406.
35. Hirayama J, Sahar S, Grimaldi B, Tamaru T, Takamatsu K, Nakahata Y, Sassone-Corsi P. CLOCK-mediated acetylation of BMAL1 controls circadian function. Nature 2007, 450:1086-1090. 10.1038/nature06394, 18075593.
36. Nakahata Y, Kaluzova M, Grimaldi B, Sahar S, Hirayama J, Chen D, Guarente LP, Sassone-Corsi P. The NAD+-dependent deacetylase SIRT1 modulates CLOCK-mediated chromatin remodeling and circadian control. Cell 2008, 134:329-340. 10.1016/j.cell.2008.07.002, 18662547.
37. Asher G, Gatfield D, Stratmann M, Reinke H, Dibner C, Kreppel F, Mostoslavsky R, Alt FW, Schibler U. SIRT1 regulates circadian clock gene expression through PER2 deacetylation. Cell 2008, 134:317-328. 10.1016/j.cell.2008.06.050, 18662546.
38. Guillaumond F, Dardente H, Giguere V, Cermakian N. Differential control of Bmal1 circadian transcription by REV-ERB and ROR nuclear receptors. J Biol Rhythms 2005, 20:391-403. 10.1177/0748730405277232, 16267379.
39. Sato TK, Panda S, Miraglia LJ, Reyes TM, Rudic RD, McNamara P, Naik KA, FitzGerald GA, Kay SA, Hogenesch JB. A functional genomics strategy reveals Rorα as a component of the mammalian circadian clock. Neuron 2004, 43:527-537. 10.1016/j.neuron.2004.07.018, 15312651.
40. Akashi M, Takumi T. The orphan nuclear receptor RORα regulates circadian transcription of the mammalian core-clock Bmal1. Nat Struct Mol Biol 2005, 12:441-448. 10.1038/nsmb925, 15821743.
41. Preitner N, Damiola F, Lopez-Molina L, Zakany J, Duboule D, Albrecht U, Schibler U. The orphan nuclear receptor REV-ERBα controls circadian transcription within the positive limb of the mammalian circadian oscillator. Cell 2002, 110:251-260. 10.1016/S0092-8674(02)00825-5, 12150932.
42. Triqueneaux G, Thenot S, Kakizawa T, Antoch MP, Safi R, Takahashi JS, Delaunay F, Laudet V. The orphan receptor Rev-erbα gene is a target of the circadian clock pacemaker. J Mol Endocrinol 2004, 33:585-608. 10.1677/jme.1.01554, 15591021.
43. Reick M, Garcia JA, Dudley C, McKnight SL. NPAS2: an analog of clock operative in the mammalian forebrain. Science 2001, 293:506-509. 10.1126/science.1060699, 11441147.
44. Amir S, Lamont EW, Robinson B, Stewart J. A circadian rhythm in the expression of PERIOD2 protein reveals a novel SCN-controlled oscillator in the oval nucleus of the bed nucleus of the stria terminalis. J Neurosci 2004, 24:781-790. 10.1523/JNEUROSCI.4488-03.2004, 14749422.
45. Lamont EW, Robinson B, Stewart J, Amir S. The central and basolateral nuclei of the amygdala exhibit opposite diurnal rhythms of expression of the clock protein Period2. Proc Natl Acad Sci USA 2005, 102:4180-4184. 10.1073/pnas.0500901102, 554834, 15746242.
46. Harms E, Kivimae S, Young MW, Saez L. Posttranscriptional and posttranslational regulation of clock genes. J Biol Rhythms 2004, 19:361-373. 10.1177/0748730404268111, 15534317.
47. Meyer P, Saez L, Young MW. PER-TIM interactions in living Drosophila cells: an interval timer for the circadian clock. Science 2006, 31:226-229.
48. Dunlap JC. Running a clock requires quality time together. Science 2006, 311:184-186. 10.1126/science.1122839, 16410512.
49. Xu Y, Padiath QS, Shapiro RE, Jones CR, Wu SC, Saigoh N, Saigoh K, Ptacek LJ, Fu YH. Functional consequences of a CKI delta mutation causing familial advanced sleep phase syndrome. Nature 2005, 434:640-644. 10.1038/nature03453, 15800623.
50. Eide EJ, Vielhaber EL, Hinz WA, Virshup DM. The circadian regulatory proteins BMAL1 and Cryptochromes are substrates of casein kinase Iε. J Biol Chem 2002, 277:17248-17254. 10.1074/jbc.M111466200, 1513548, 11875063.
51. Yang Y, Cheng P, Liu Y. Regulation of the Neurospora circadian clock by casein kinase II. Genes Dev 2002, 16:994-1006. 10.1101/gad.965102, 152355, 11959847.
52. Yang Y, Cheng P, He Q, Wang L, Liu Y. Phosphorylation of FREQUENCY protein by casein kinase II is necessary for the function of the Neurospora circadian clock. Mol Cell Biol 2003, 23:6221-6228. 10.1128/MCB.23.17.6221-6228.2003, 180927, 12917343.
53. Lin JM, Kilman VL, Keegan K, Paddock B, Emery-Le M, Rosbash M, Allada R. A role for casein kinase 2α in the Drosophila circadian clock. Nature 2002, 420:816-820. 10.1038/nature01235, 12447397.
54. Lin JM, Schroeder A, Allada R. In vivo circadian function of casein kinase 2 phosphorylation sites in Drosophila PERIOD. J Neurosci 2005, 25:11175-11183. 10.1523/JNEUROSCI.2159-05.2005, 16319317.
55. Akten B, Jauch E, Genova GK, Kim EY, Edery I, Raabe T, Jackson FR. A role for CK2 in the Drosophila circadian oscillator. Nature Neurosci 2003, 6:251-257. 10.1038/nn1007, 12563262.
56. Iitaka C, Miyazaki K, Akaike T, Ishida N. A role for glycogen synthase kinase-3β in the mammalian circadian clock. J Biol Chem 2005, 280:29397-29402. 10.1074/jbc.M503526200, 15972822.
57. Yin L, Wang J, Klein PS, Lazar MA. Nuclear receptor Rev-erbα is a critical lithium-sensitive component of the circadian clock. Science 2006, 311:1002-1005. 10.1126/science.1121613, 16484495.
58. Harada Y, Sakai M, Kurabayashi N, Hirota T, Fukada Y. Ser-557-phosphorylated mCRY2 is degraded upon synergistic phosphorylation by glycogen synthase kinase-3β. J Biol Chem 2005, 280:31714-31721. 10.1074/jbc.M506225200, 15980066.
59. Lamia KA, Sachdeva UM, DiTacchio L, Williams EC, Alvarez JG, Egan DF, Vasquez DS, Juguilon H, Panda S, Shaw RJ, Thompson CB, Evans RM. AMPK regulates the circadian clock by cryptochrome phosphorylation and degradation. Science 2009, 326:437-440. 10.1126/science.1172156, 2819106, 19833968.
60. Vieira E, Nilsson EC, Nerstedt A, Ormestad M, Long YC, Garcia-Roves PM, Zierath JR, Mahlapuu M. Relationship between AMPK and the transcriptional balance of clock-related genes in skeletal muscle. Am J Physiol Endocrinol Metab 2008, 295:1032-1037.
61. Partch CL, Shields KF, Thompson CL, Selby CP, Sancar A. Posttranslational regulation of the mammalian circadian clock by cryptochrome and protein phosphatase 5. Proc Natl Acad Sci USA 2006, 103:10467-10472. 10.1073/pnas.0604138103, 1502481, 16790549.
62. Rivers A, Gietzen KF, Vielhaber E, Virshup DM. Regulation of casein kinase Iε and casein kinase Iδ by an in vivo futile phosphorylation cycle. J Biol Chem 1998, 273:15980-15984. 10.1074/jbc.273.26.15980, 9632646.
63. Cegielska A, Gietzen KF, Rivers A, Virshup DM. Autoinhibition of casein kinase Iε (CKIε) is relieved by protein phosphatases and limited proteolysis. J Biol Chem 1998, 273:1357-1364. 10.1074/jbc.273.3.1357, 9430669.
64. Eide EJ, Woolf MF, Kang H, Woolf P, Hurst W, Camacho F, Vielhaber EL, Giovanni A, Virshup DM. Control of mammalian circadian rhythm by CKIε-regulated proteasome-mediated PER2 degradation. Mol Cell Biol 2005, 25:2795-2807. 10.1128/MCB.25.7.2795-2807.2005, 1061645, 15767683.
65. Shirogane T, Jin J, Ang XL, Harper JW. SCFβ- TRCP controls clock-dependent transcription via casein kinase 1-dependent degradation of the mammalian period-1 (Per1) protein. J Biol Chem 2005, 280:26863-26872. 10.1074/jbc.M502862200, 15917222.
66. Cardone L, Hirayama J, Giordano F, Tamaru T, Palvimo JJ, Sassone-Corsi P. Circadian clock control by SUMOylation of BMAL1. Science 2005, 309:1390-1394. 10.1126/science.1110689, 16109848.
67. Duffield GE. DNA microarray analyses of circadian timing: the genomic basis of biological time. J Neuroendocrinol 2003, 15:991-1002. 10.1046/j.1365-2826.2003.01082.x, 12969245.
68. Hunt T, Sassone-Corsi P. Riding tandem: Circadian clocks and the cell cycle. Cell 2007, 129:461-464. 10.1016/j.cell.2007.04.015, 17482541.
69. Matsuo T, Yamaguchi S, Mitsui S, Emi A, Shimoda F, Okamura H. Control mechanism of the circadian clock for timing of cell division in vivo. Science 2003, 302:255-259. 10.1126/science.1086271, 12934012.
70. Fu L, Pelicano H, Liu J, Huang P, Lee C. The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 2002, 111:41-50. 10.1016/S0092-8674(02)00961-3, 12372299.
71. Oishi K, Miyazaki K, Kadota K, Kikuno R, Nagase T, Atsumi G, Ohkura N, Azama T, Mesaki M, Yukimasa S, Kobayashi H, Iitaka C, Umehara T, Horikoshi M, Kudo T, Shimizu Y, Yano M, Monden M, Machida K, Matsuda J, Horie S, Todo T, Ishida N. Genome-wide expression analysis of mouse liver reveals CLOCK-regulated circadian output genes. J Biol Chem 2003, 278:41519-41527. 10.1074/jbc.M304564200, 12865428.
72. Nyberg KA, Michelson RJ, Putnam CW, Weinert TA. Toward maintaining the genome: DNA damage and replication checkpoints. Annu Rev Genet 2002, 36:617-656. 10.1146/annurev.genet.36.060402.113540, 12429704.
73. Sancar A, Lindsey-Boltz LA, Unsal-Kacmaz K, Linn S. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem 2004, 73:39-85. 10.1146/annurev.biochem.73.011303.073723, 15189136.
74. Hogenesch JB, Panda S, Kay S, Takahashi JS. Circadian transcriptional output in the SCN and liver of the mouse. Novartis Found Symp 2003, 253:171-180. full_text, 14712921.
75. You Z, Saims D, Chen S, Zhang Z, Guttridge DC, Guan KL, MacDougald OA, Brown AM, Evan G, Kitajewski J, Wang CY. Wnt signaling promotes oncogenic transformation by inhibiting c-Myc-induced apoptosis. J Cell Biol 2002, 157:429-440. 10.1083/jcb.200201110, 2173296, 11980918.
76. Pucci B, Kasten M, Giordano A. Cell cycle and apoptosis. Neoplasia 2000, 2:291-299. 10.1038/sj.neo.7900101, 1550296, 11005563.
77. Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature 2001, 411:342-348. 10.1038/35077213, 11357141.
78. Vafa O, Wade M, Kern S, Beeche M, Pandita TK, Hampton GM, Wahl GM. c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability. Mol Cell 2002, 9:1031-1044. 10.1016/S1097-2765(02)00520-8, 12049739.
79. Sheen JH, Dickson RB. Overexpression of c-Myc alters G1-S arrest following ionizing radiation. Mol Cell Biol 2002, 22:1819-1833. 10.1128/MCB.22.6.1819-1833.2002, 135614, 11865060.
80. Vafa O, Wade M, Kern S, Beeche M, Pandita TK, Hampton GM, Wahl GM. c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for ontogeny-induced genetic instability. Mol Cell 2002, 9:1031-1044. 10.1016/S1097-2765(02)00520-8, 12049739.
81. Roy PG, Thompson AM. Cyclin D1 and breast cancer. Breast 2006, 15:718-727. 10.1016/j.breast.2006.02.005, 16675218.
82. Gréchez-Cassiau A, Rayet B, Guillaumond F, Teboul M, Delaunay F. The circadian clock component BMAL1 is a critical regulator of p21WAF1/CIP1 expression and hepatocyte proliferation. J Biol Chem 2008, 283:4535-4542. 10.1074/jbc.M705576200, 18086663.
83. Antoch MP, Kondratov RV. Circadian proteins and genotoxic stress response. Circ Res 2010, 106:68-78. 10.1161/CIRCRESAHA.109.207076, 20056947.
84. Riley T, Sontag E, Chen P, Levine A. Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol 2008, 9:402-412. 10.1038/nrm2395, 18431400.
85. Mullenders J, Fabius AW, Madiredjo M, Bernards R, Beijersbergen RL. A large scale shRNA barcode screen identifies the circadian clock component ARNTL as putative regulator of the p53 tumor suppressor pathway. PloS One 2009, 4:e4798. 10.1371/journal.pone.0004798, 2653142, 19277210.
86. Gery S, Komatsu N, Baldjyan L, Yu A, Koo D, Koeffler HP. The circadian gene per1 plays an important role in cell growth and DNA damage control in human cancer cells. Mol Cell 2006, 22:375-382. 10.1016/j.molcel.2006.03.038, 16678109.
87. Barnes JW, Tischkau SA, Barnes JA, Mitchell JW, Burgoon PW, Hickok JR, Gillette MU. Requirement of mammalian Timeless for circadian rhythmicity. Science 2003, 302:439-442. 10.1126/science.1086593, 14564007.
88. Unsal-Kacmaz K, Mullen TE, Kaufmann WK, Sancar A. Coupling of human circadian and cell cycles by the timeless protein. Mol Cell Biol 2005, 25:3109-3116. 10.1128/MCB.25.8.3109-3116.2005, 1069621, 15798197.
89. Wood PA, Yang X, Taber A, Oh EY, Ansell C, Ayers SE, Al-Assaad Z, Carnevale K, Berger FG, Pena MM, Hrushesky WJ. Period 2 mutation accelerates ApcMin/+ tumorigenesis. Mol Cancer Res 2008, 6:1786-1793. 10.1158/1541-7786.MCR-08-0196, 19010825.
90. Yang X, Wood PA, Ansell CM, Ohmori M, Oh EY, Xiong Y, Berger FG, Pena MM, Hrushesky WJ. Beta-catenin induces beta-TrCP-mediated PER2 degradation altering circadian clock gene expression in intestinal mucosa of ApcMin/+ mice. J Biochem 2009, 145:289-297. 10.1093/jb/mvn167, 19106159.
91. Hua H, Wang Y, Wan C, Liu Y, Zhu B, Yang C, Wang X, Wang Z, Cornelissen-Guillaume G, Halberg F. Circadian gene mPer2 overexpression induces cancer cell apoptosis. Cancer Sci 2006, 97:589-596. 10.1111/j.1349-7006.2006.00225.x, 2662332, 16827798.
92. Hua H, Wang Y, Wan C, Liu Y, Zhu B, Wang X, Wang Z, Ding JM. Inhibition of tumorigenesis by intratumoral delivery of the circadian gene mPer2 in C57BL/6 mice. Cancer Gene Ther 2007, 14:815-818. 10.1038/sj.cgt.7701061, 17589433.
93. Gauger MA, Sancar A. Cryptochrome, Circadian Cycle, Cell Cycle Checkpoints, and Cancer. Cancer Res 2005, 65:6828-6834. 10.1158/0008-5472.CAN-05-1119, 16061665.
94. Kondratov RV, Kondratova AA, Gorbacheva VY, Vykhovanets OV, Antoch MP. Early aging and age-related pathologies in mice deficient in BMAL1, the core component of the circadian clock. Genes Dev 2006, 20:1868-1873. 10.1101/gad.1432206, 16847346.
95. Antoch MP, Gorbacheva VY, Vykhovanets O, Toshkov IA, Kondratov RV, Kondratova AA, Lee C, Nikitin AY. Disruption of the circadian clock due to the Clock mutation has discrete effects on aging and carcinogenesis. Cell Cycle 2008, 7:1197-1204. 2744375, 18418054.
96. Ozturk N, Lee JH, Gaddameedhi S, Sancar A. Loss of cryptochrome reduces cancer risk in p53 mutant mice. Proc Natl Acad Sci USA 2009, 106:2841-2846. 10.1073/pnas.0813028106, 2634797,2634797, 19188586.
97. Kang TH, Reardon JT, Kemp M, Sancar A. Circadian oscillation of nucleotide excision repair in mammalian brain. Proc Natl Acad Sci USA 2009, 106:2864-2867. 10.1073/pnas.0812638106, 2629438,2629438, 19164551.
98. Schernhammer ES, Laden F, Speizer FE, Willett WC, Hunter DJ, Kawachi I, Colditz GA. Rotating night shifts and risk of breast cancer in women participating in the nurses' health study. J Natl Cancer Inst 2001, 93:1563-1568.
99. Hansen J. Risk of breast cancer after night- and shift work: current evidence and ongoing studies in Denmark. Cancer Causes Control 2006, 17:531-537. 10.1007/s10552-005-9006-5, 16596307.
100. Stevens RG. Artificial lighting in the industrialized world: Circadian disruption and breast cancer. Cancer Causes Control 2006, 17:501-507. 10.1007/s10552-005-9001-x, 16596303.
101. Davis S, Mirick DK. Circadian disruption, shift work and the risk of cancer: a summary of the evidence and studies in Seattle. Cancer Causes Control 2006, 17:539-545. 10.1007/s10552-005-9010-9, 16596308.
102. Keith LG, Oleszczuk JJ, Laguens M. Circadian rhythm chaos: a new breast cancer marker. Int J Fertil Womens Med 2001, 46:238-247.
103. Pushkala K, Gupta PD. Prevalence of breast cancer in menopausal blind women. IJMMS 2009, 1:425-431.
104. Viswanathan AN, Hankinson SE, Schernhammer ES. Night Shift Work and the Risk of Endometrial Cancer. Cancer Res 2007, 67:10618-10622. 10.1158/0008-5472.CAN-07-2485, 17975006.
105. Band PR, Le ND, Fang R, Deschamps M, Coldman AJ, Gallagher RP, Moody J. Cohort study of Air Canada pilots: mortality, cancer incidence, and leukemia risk. Am J Epidemiol 1996, 143:13-43.
106. Pukkala E, Aspholm R, Auvinen A, Eliasch H, Gundestrup M, Haldorsen T, Hammar N, Hrafnkelsson J, Kyyrönen P, Linnersjö A, Rafnsson V, Storm H, Tveten U. Cancer incidence among 10,211 airline pilots: a Nordic study. Aviat Space Environ Med 2003, 74:699-706.
107. Kubo T, Ozasa K, Mikami K, Wakai K, Fujino Y, Watanabe Y, Miki T, Nakao M, Hayashi K, Suzuki K, Mori M, Washio M, Sakauchi F, Ito Y, Yoshimura T, Tamakoshi A. Prospective Cohort Study of the Risk of Prostate Cancer among Rotating-Shift Workers: Findings from the Japan Collaborative Cohort Study. Am J Epidemiol 2006, 164:549-555. 10.1093/aje/kwj232, 16829554.
108. Band PR, Le ND, Fang R, Deschamps M, Coldman AJ, Gallagher RP, Moody J. Cohort study of Air Canada pilots: mortality, cancer incidence, and leukemia risk. Am J Epidemiol 1996, 143:13-43.
109. Schernhammer ES, Laden F, Speizer FE, Willett WC, Hunter DJ, Kawachi I, Fuchs CS, Colditz GA. Night-Shift Work and Risk of Colorectal Cancer in the Nurses' Health Study. J Natl Cancer Inst 2003, 95:825-828.
110. Mormont MC, Waterhouse J, Bleuzen P, Giacchetti S, Jami A, Bogdan A, Lellouch J, Misset JL, Touitou Y, Levi. Marked 24-h rest/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status. Clin Cancer Res 6:3038-3045.
111. Chen ST, Choo KB, Hou MF, Yeh KT, Kuo SJ, Chang JG. Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers. Carcinogenesis 2005, 26:1241-1246. 10.1093/carcin/bgi075, 15790588.
112. Zhu Y, Brown HN, Zhang Y, Stevens RG, Zheng T. Period3 structural variation: a circadian biomarker associated with breast cancer in young women. Cancer Epidemiol Biomarkers Prev 2005, 14:268-270.
113. Winter SL, Bosnoyan-Collins L, Pinnaduwage D, Andrulis IL. Expression of the Circadian Clock Genes Per1 and Per2 in Sporadic and Familial Breast Tumors. Neoplasia 2007, 9:797-800. 10.1593/neo.07595, 2040206, 17971899.
114. Xiang S, Coffelt SB, Mao L, Yuan L, Cheng Q, Hill SM. Period-2: a tumor suppressor gene in breast cancer. Journal of Circadian Rhythms 2008, 6:4. 10.1186/1740-3391-6-4, 2365929, 18334030.
115. Klevecz RR, Shymko RM, Blumenfeld D, Braly PS. Circadian gating of S phase in human ovarian cancer. Cancer Res 1987, 47:6267-6271.
116. Klevecz RR, Braly PS. Circadian and ultradian rhythms of proliferation in human ovarian cancer. Chronobiol Int 1987, 4:513-523. 10.3109/07420528709078543, 3435929.
117. Tokunaga H, Takebayashi Y, Utsunomiya H, Akahira J, Higashimoto M, Mashiko M, Ito K, Niikura H, Takenoshita S, Yaegashi N. Clinicopathological significance of circadian rhythm-related gene expression levels in patients with epithelial ovarian cancer. Acta Obstetricia et Gynecologica 2008, 87:1060-1070.
118. Yeh KT, Yang MY, Liu TC, Chen JC, Chan WL, Lin SF, Chang JG. Abnormal expression of period I (PERI) in endometrial carcinoma. J Pathol 2005, 206:111-120. 10.1002/path.1756, 15809976.
119. Shih MC, Yeh KT, Tang KP, Chen JC, Chang JG. Promoter methylation in circadian genes of endometrial cancers. Mol Carcinog 2006, 45:732-740. 10.1002/mc.20198, 16683245.
120. Cao Q, Gery S, Dashti A, Yin D, Zhou Y, Gu J, Koeffler HP. A Role for the Clock Gene Per1 in Prostate Cancer. Cancer Res 2001, 69:7619-7625.
121. Gery S, Gombart AF, Yi WS, Koeffler C, Hofmann WK, Koeffler HP. Transcription profiling of C/EBP targets identifies Per2 as a gene implicated in myeloid leukemia. Blood 2005, 106:2827-2836. 10.1182/blood-2005-01-0358, 1895299, 15985538.
122. Yang MY, Chang JG, Lin PM, Tang KP, Chen YH, Lin HY, Liu TC, Hsiao HH, Liu YC, Lin SF. Downregulation of circadian clock genes in chronic myeloid leukemia: Alternative methylation pattern of hPER3. Cancer Sci 2006, 97:1298-1307. 10.1111/j.1349-7006.2006.00331.x, 16999817.
123. Lewintre EJ, Martín CR, Ballesteros CG, Montaner D, Rivera R, Mayans JR, García-Conde J. Cryptochrome-1 expression: a new prognostic marker in B-cell chronic lymphocytic leukemia. Haematologica| 2008, 94:280-284.
124. Eisele L, Prinz R, Klein-Hitpass L, Nückel H, Lowinski K, Thomale J, Moeller LC, Dührsen U, Dürig J. Combined PER2 and CRY1 expression predicts outcome in chronic lymphocytic leukemia. Eur J Haematol 2009, 83:320-327. 10.1111/j.1600-0609.2009.01287.x, 19500131.
125. Spathis A, Morrish E, Booth S, Smith IE, Shneerson JM. Selective circadian rhythm disturbance in cerebral lymphoma. Sleep Med 2003, 4:583-586. 10.1016/S1389-9457(03)00161-8, 14607354.
126. Hoffman AE, Zheng T, Stevens RG, Ba Y, Zhang Y, Leaderer D, Yi C, Holford TR, Zhu Y. Clock-Cancer Connection in Non-Hodgkin's Lymphoma: A Genetic Association Study and Pathway Analysis of the Circadian Gene Cryptochrome 2. Cancer Res 2009, 69:3605-3613. 10.1158/0008-5472.CAN-08-4572, 19318546.
127. Pogue-Geile KL, Lyons-Weiler J, Whitcomb DC. Molecular overlap of fly circadian rhythms and human pancreatic cancer. Cancer Lett 2006, 243:55-57. 10.1016/j.canlet.2005.11.049, 16451817.
128. Gery S, Komatsu N, Kawamata N, Miller CW, Desmond J, Virk RK, Marchevsky A, McKenna R, Taguchi H, Koeffler HP. Epigenetic silencing of the candidate tumor suppressor gene Per1 in non-small cell lung cancer. Clin Cancer Res 2007, 13:1399-1404. 10.1158/1078-0432.CCR-06-1730, 17332281.
129. Taniguchi H, Fernández AF, Setién F, Ropero S, Ballestar E, Villanueva A, Yamamoto H, Imai K, Shinomura Y, Esteller M. Epigenetic inactivation of the circadian clock gene BMAL1 in hematologic malignancies. Cancer Res 2009, 69:8447-8454. 10.1158/0008-5472.CAN-09-0551, 19861541.
130. Mulero-Navarro S, Esteller M. Epigenetic biomarkers for human cancer: the time is now. Crit Rev Oncol Hematol 2008, 68:1-11. 10.1016/j.critrevonc.2008.03.001, 18430583.
131. Kaminskas E, Farrell A, Abraham S, Baird A, Hsieh LS, Lee SL, Leighton JK, Patel H, Rahman A, Sridhara R, Wang YC, Pazdur R, . FDA Approval summary: azacitidine for treatment of myelodysplastic syndrome subtypes. Clin Cancer Res 2005, 11:3604-3608. 10.1158/1078-0432.CCR-04-2135, 15897554, FDA.
132. Issa JP, Gharibyan V, Cortes J, Jelinek J, Morris G, Verstovsek S, Talpaz M, Garcia-Manero G, Kantarjian HM. Phase II study of low-dose decitabine in patients with chronic myelogenous leukemia resistant to imatinib mesylate. J Clin Oncol 2005, 23:3948-3956. 10.1200/JCO.2005.11.981, 15883410.
133. Fu L, Lee CC. The circadian clock: pacemaker and tumour suppressor. Nat Rev Cancer 2003, 3:350-361. 10.1038/nrc1072, 12724733.
134. Sahar S, Sassone-Corsi P. Metabolism and cancer: the circadian clock connection. Nat Rev Cancer 2009, 9:886-896. 10.1038/nrc2747, 19935677.
135. Filipski E, Lévi F. Circadian disruption in experimental cancer processes. Integr Cancer Ther 2009, 8(4):298-302. 10.1177/1534735409352085, 20042408.
136. Lee CC. Tumor suppression by the mammalian Period genes. Cancer Causes Control 2006, 17:525-530. 10.1007/s10552-005-9003-8, 16596306.
137. Hanahan D, Weinberg RA. The hallmarks of cancer: A review. Cell 2000, 100:57-70. 10.1016/S0092-8674(00)81683-9, 10647931.
138. Kondratov RV, Kondratova AA, Gorbacheva VY, Vykhovanets OV, Antoch MP. Early aging and age-related pathologies in mice deficient in BMAL1, the core component of the circadian clock. Genes Dev 2006, 20:1868-1873. 10.1101/gad.1432206, 1522083, 16847346.
139. Gauger MA, Sancar A. Cryptochrome, Circadian Cycle, Cell Cycle Checkpoints, and Cancer. Cancer Res 2005, 65:6828-6834. 10.1158/0008-5472.CAN-05-1119, 16061665.
140. Wang CY, Wen MS, Wang HW, Hsieh IC, Li Y, Liu PY, Lin FC, Liao JK. Increased vascular senescence and impaired endothelial progenitor cell function mediated by mutation of circadian gene Per2. Circulation 2008, 118:2166-2173. 10.1161/CIRCULATIONAHA.108.790469, 2656770, 18981300.
141. Campisi J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 2005, 120:513-522. 10.1016/j.cell.2005.02.003, 15734683.
142. Lévi F, Okyar A, Dulong S, Innominato PF, Clairambault J. Circadian timing in cancer treatments. Annu Rev Pharmacol Toxicol 2010, 50:377-421. 10.1146/annurev.pharmtox.48.113006.094626, 20055686.
143. Lévi F, Schibler U. Circadian rhythms: Mechanisms and therapeutic implications. Annu Rev Pharmacol Toxicol 2007, 47:593-628. 10.1146/annurev.pharmtox.47.120505.105208, 17209800.
144. Mormont MC, Lévi F. Cancer chronotherapy: Principles, applications, and perspectives. Cancer 2003, 97:155-169. 10.1002/cncr.11040, 12491517.
145. Lévi F. Chronopharmacology of anticancer agents. Physiology and Pharmacology of Biological Rhythms 1997, 299-33. Berlin: Springer-Verlag, Redfern P, Lemmer B.
146. Altinok A, Lévi F, Goldbeter A. Identifying mechanisms of chronotolerance and chronoefficacy for the anticancer drugs 5-fluorouracil and oxaliplatin by computational modeling. Eur J Pharm Sci 2009, 36:20-38. 10.1016/j.ejps.2008.10.024, 19041394.
147. Gorbacheva VY, Kondratov RV, Zhang R, Cherukuri S, Gudkov AV, Takahashi JS, Antoch MP. Circadian sensitivity to the chemotherapeutic agent cyclophosphamide depends on the functional status of the CLOCK/BMAL1 transactivation complex. Proc Natl Acad Sci USA 2005, 102:3407-3712. 10.1073/pnas.0409897102, 546637,546637, 15689397.